Barrett’s Esophagus and Esophageal Carcinoma: Can Biomarkers Guide Clinical Practice?

Vani J.A. Konda, Rhonda F Souza

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Purpose of Review: Despite gastrointestinal societal recommendations for endoscopic screening and surveillance of Barrett’s esophagus, the rates of esophageal adenocarcinoma continue to rise. Furthermore, this current practice is costly to patients and the medical system without clear evidence of reduction in cancer mortality. The use of biomarkers to guide screening, surveillance, and treatment strategies might alleviate some of these issues. Recent Findings: Incredible advances in biomarker identification, biomarker assays, and minimally-invasive modalities to acquire biomarkers have shown promising results. Summary: We will highlight recently published, key studies demonstrating where we are with using biomarkers for screening and surveillance in clinical practice, and what is on the horizon regarding novel non-invasive and minimally invasive methods to acquire biomarkers. Proof-of principle studies using in silico models demonstrate that biomarker-guided screening, surveillance, and therapeutic intervention strategies can be cost-effective and can reduce cancer deaths in patients with Barrett’s esophagus.

Original languageEnglish (US)
Article number14
JournalCurrent Gastroenterology Reports
Volume21
Issue number4
DOIs
StatePublished - Apr 1 2019
Externally publishedYes

Fingerprint

Barrett Esophagus
Biomarkers
Carcinoma
Computer Simulation
Neoplasms
Adenocarcinoma
Costs and Cost Analysis
Mortality
Therapeutics

Keywords

  • Endoscopic
  • Gastroesophageal reflux disease
  • Imaging
  • Screening
  • Surveillance
  • Tissue

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Barrett’s Esophagus and Esophageal Carcinoma : Can Biomarkers Guide Clinical Practice? / Konda, Vani J.A.; Souza, Rhonda F.

In: Current Gastroenterology Reports, Vol. 21, No. 4, 14, 01.04.2019.

Research output: Contribution to journalReview article

@article{1a7498a56d3a4fa79656c7844f60274e,
title = "Barrett’s Esophagus and Esophageal Carcinoma: Can Biomarkers Guide Clinical Practice?",
abstract = "Purpose of Review: Despite gastrointestinal societal recommendations for endoscopic screening and surveillance of Barrett’s esophagus, the rates of esophageal adenocarcinoma continue to rise. Furthermore, this current practice is costly to patients and the medical system without clear evidence of reduction in cancer mortality. The use of biomarkers to guide screening, surveillance, and treatment strategies might alleviate some of these issues. Recent Findings: Incredible advances in biomarker identification, biomarker assays, and minimally-invasive modalities to acquire biomarkers have shown promising results. Summary: We will highlight recently published, key studies demonstrating where we are with using biomarkers for screening and surveillance in clinical practice, and what is on the horizon regarding novel non-invasive and minimally invasive methods to acquire biomarkers. Proof-of principle studies using in silico models demonstrate that biomarker-guided screening, surveillance, and therapeutic intervention strategies can be cost-effective and can reduce cancer deaths in patients with Barrett’s esophagus.",
keywords = "Endoscopic, Gastroesophageal reflux disease, Imaging, Screening, Surveillance, Tissue",
author = "Konda, {Vani J.A.} and Souza, {Rhonda F}",
year = "2019",
month = "4",
day = "1",
doi = "10.1007/s11894-019-0685-6",
language = "English (US)",
volume = "21",
journal = "Current Gastroenterology Reports",
issn = "1522-8037",
publisher = "Current Medicine Group",
number = "4",

}

TY - JOUR

T1 - Barrett’s Esophagus and Esophageal Carcinoma

T2 - Can Biomarkers Guide Clinical Practice?

AU - Konda, Vani J.A.

AU - Souza, Rhonda F

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Purpose of Review: Despite gastrointestinal societal recommendations for endoscopic screening and surveillance of Barrett’s esophagus, the rates of esophageal adenocarcinoma continue to rise. Furthermore, this current practice is costly to patients and the medical system without clear evidence of reduction in cancer mortality. The use of biomarkers to guide screening, surveillance, and treatment strategies might alleviate some of these issues. Recent Findings: Incredible advances in biomarker identification, biomarker assays, and minimally-invasive modalities to acquire biomarkers have shown promising results. Summary: We will highlight recently published, key studies demonstrating where we are with using biomarkers for screening and surveillance in clinical practice, and what is on the horizon regarding novel non-invasive and minimally invasive methods to acquire biomarkers. Proof-of principle studies using in silico models demonstrate that biomarker-guided screening, surveillance, and therapeutic intervention strategies can be cost-effective and can reduce cancer deaths in patients with Barrett’s esophagus.

AB - Purpose of Review: Despite gastrointestinal societal recommendations for endoscopic screening and surveillance of Barrett’s esophagus, the rates of esophageal adenocarcinoma continue to rise. Furthermore, this current practice is costly to patients and the medical system without clear evidence of reduction in cancer mortality. The use of biomarkers to guide screening, surveillance, and treatment strategies might alleviate some of these issues. Recent Findings: Incredible advances in biomarker identification, biomarker assays, and minimally-invasive modalities to acquire biomarkers have shown promising results. Summary: We will highlight recently published, key studies demonstrating where we are with using biomarkers for screening and surveillance in clinical practice, and what is on the horizon regarding novel non-invasive and minimally invasive methods to acquire biomarkers. Proof-of principle studies using in silico models demonstrate that biomarker-guided screening, surveillance, and therapeutic intervention strategies can be cost-effective and can reduce cancer deaths in patients with Barrett’s esophagus.

KW - Endoscopic

KW - Gastroesophageal reflux disease

KW - Imaging

KW - Screening

KW - Surveillance

KW - Tissue

UR - http://www.scopus.com/inward/record.url?scp=85062870317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062870317&partnerID=8YFLogxK

U2 - 10.1007/s11894-019-0685-6

DO - 10.1007/s11894-019-0685-6

M3 - Review article

C2 - 30868278

AN - SCOPUS:85062870317

VL - 21

JO - Current Gastroenterology Reports

JF - Current Gastroenterology Reports

SN - 1522-8037

IS - 4

M1 - 14

ER -